Trials / Not Yet Recruiting
Not Yet RecruitingNCT07243067
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Conditions
- Renal Cell Carcinoma
- Clear-cell Renal Cell Carcinoma
- Papillary Renal Cell Carcinoma
- Chromophobe Renal Cell Carcinoma
- Kidney Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Proteomic profiling of urinary EVs | EV isolation and mass spectrometry. |
| PROCEDURE | Blood sample collection | Blood samples collected pre- and post-nephrectomy |
Timeline
- Start date
- 2026-07-15
- Primary completion
- 2027-04-30
- Completion
- 2027-04-30
- First posted
- 2025-11-21
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07243067. Inclusion in this directory is not an endorsement.